Lihua Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lihua Chen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Jingjing Qiu
Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen 518100, P. R. China; Postgraduate college, Guangzhou University of Chinese Medicine, Guangzhou 510080, P. R. China
1 shared publication- Lei Wan
The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510378, China
1 shared publication Muhammad Attique Khan
Department of Computer Science and Mathematics, Lebanese American University, Beirut, Lebanon
1 shared publicationQing‐Lin Li
Department of Acupuncture and Massage The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine Shenzhen China
1 shared publication- Xiang‐Hui Xu
Department of Critical Care Medicine Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine Shenzhen China
1 shared publication Yang Jiang
Department of Rehabilitation Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine Shenzhen China
1 shared publication
Latest Publications
- 15 April 2026
- Published by Wiley in Nursing in Critical Care
- Vol. 31 (3) , e70469
Machine Learning Interpretability to Assess the Association Between Time in Tight Range and Mortality in Cardiogenic Shock
Background: Cardiogenic shock (CS) is a critical condition of end‐organ hypoperfusion with high mortality. Fluctuations in blood glucose (BG) levels may exacerbate cardiovascular instability in critically ill patients. Time In Tight Range (TITR), defined as the percentage of time in the target BG range of 3.9–7.8 mmol/L (70–140 mg/dL), has become an increasingly important index of glycaemic status, but its impact on mortality in CS remains unclear. Interpretable machine learning (ML) models provide transparent, quantitative and visual insights into the prognostic importance of TITR, clarifying its pivotal role in outcome prediction and providing objective evidence to support individualised glucose management. Aim: This study aimed to investigate the relationship between TITR and mortality in patients with CS, and to provide strong evidence for early intervention and personalised blood glucose management. Study Design: We conducted a retrospective multi‐cohort study to examine the association between TITR and mortality in patients with CS. The relationship between TITR and in‐hospital mortality was analysed using a restricted cubic spline (RCS) model, log‐rank test, multivariable Cox and logistic regression analyses. ML models, including XGBoost, LightGBM, CatBoost, Gradient Boosting, Support Vector Machine (SVM), Neural Network and Naive Bayes, were developed to predict mortality and compared with traditional clinical scoring systems. Model interpretability was assessed using SHapley Additive exPlanations (SHAP). Sensitivity and subgroup analyses were used to reveal the robustness of the results. Results: RCS analysis revealed an inverse (L‐shaped) association ( p < 0.001) between TITR and in‐hospital mortality in both the Medical Information Mart for Intensive Care IV (MIMIC‐IV) and the eICU Collaborative Research Database (eICU) cohorts. Kaplan–Meier survival analyses revealed the patients with TITR > 57% (High TITR group) had significantly lower in‐hospital mortality than those with TITR ≤ 57% (Low TITR group) in both cohorts. The hazard ratios (HRs) (95% confidence interval [CI]) estimated by log‐rank test were 1.72 (1.49, 1.99) and 1.49 (1.19, 1.87) in the MIMIC‐IV and eICU cohorts, respectively (both p < 0.001). Sensitivity analyses yielded consistent results, confirming the robustness of the findings. In addition, analyses of ICU mortality, 28‐day mortality (only available in the MIMIC‐IV cohort), also demonstrated a consistent pattern with the primary outcome. Based on area under curve values (AUC), ML models, including CatBoost (AUC = 0.76; 95% CI: 0.73–0.80 in MIMIC‐IV; 0.77; 95% CI: 0.72–0.83 in eICU), Gradient Boosting (AUC = 0.75; 95% CI: 0.72–0.79 and 0.74; 95% CI: 0.68–0.80) and XGBoost (AUC = 0.74; 95% CI: 0.70–0.77 and 0.76; 95% CI: 0.71–0.82), outperformed traditional scoring systems. Interpretability analysis via SHAP consistently highlighted TITR as the most influential factor in mortality prediction. Conclusions: These findings underscore the critical role of TITR in outcome prediction and demonstrate both the superiority and interpretability of ML models for risk stratification and decision support. Achieving higher TITR is associated with improved outcomes, highlighting the importance of dynamic glucose control in this population. Relevance to Clinical Practice: The findings offer evidence‐based guidance for ICU nursing interventions, highlighting TITR as a key modifiable factor for improving outcomes for patients with CS. The strong performance of ML models supports their clinical application for more accurate risk stratification, while identification of TITR as the primary mortality predictor—reinforced by transparent SHAP explanations—provides actionable insights to guide early, targeted interventions.
- 15 April 2026
- Published by Wiley in Nursing in Critical Care
- Vol. 31 (3) , e70469
Machine Learning Interpretability to Assess the Association Between Time in Tight Range and Mortality in Cardiogenic Shock
Background: Cardiogenic shock (CS) is a critical condition of end‐organ hypoperfusion with high mortality. Fluctuations in blood glucose (BG) levels may exacerbate cardiovascular instability in critically ill patients. Time In Tight Range (TITR), defined as the percentage of time in the target BG range of 3.9–7.8 mmol/L (70–140 mg/dL), has become an increasingly important index of glycaemic status, but its impact on mortality in CS remains unclear. Interpretable machine learning (ML) models provide transparent, quantitative and visual insights into the prognostic importance of TITR, clarifying its pivotal role in outcome prediction and providing objective evidence to support individualised glucose management. Aim: This study aimed to investigate the relationship between TITR and mortality in patients with CS, and to provide strong evidence for early intervention and personalised blood glucose management. Study Design: We conducted a retrospective multi‐cohort study to examine the association between TITR and mortality in patients with CS. The relationship between TITR and in‐hospital mortality was analysed using a restricted cubic spline (RCS) model, log‐rank test, multivariable Cox and logistic regression analyses. ML models, including XGBoost, LightGBM, CatBoost, Gradient Boosting, Support Vector Machine (SVM), Neural Network and Naive Bayes, were developed to predict mortality and compared with traditional clinical scoring systems. Model interpretability was assessed using SHapley Additive exPlanations (SHAP). Sensitivity and subgroup analyses were used to reveal the robustness of the results. Results: RCS analysis revealed an inverse (L‐shaped) association ( p < 0.001) between TITR and in‐hospital mortality in both the Medical Information Mart for Intensive Care IV (MIMIC‐IV) and the eICU Collaborative Research Database (eICU) cohorts. Kaplan–Meier survival analyses revealed the patients with TITR > 57% (High TITR group) had significantly lower in‐hospital mortality than those with TITR ≤ 57% (Low TITR group) in both cohorts. The hazard ratios (HRs) (95% confidence interval [CI]) estimated by log‐rank test were 1.72 (1.49, 1.99) and 1.49 (1.19, 1.87) in the MIMIC‐IV and eICU cohorts, respectively (both p < 0.001). Sensitivity analyses yielded consistent results, confirming the robustness of the findings. In addition, analyses of ICU mortality, 28‐day mortality (only available in the MIMIC‐IV cohort), also demonstrated a consistent pattern with the primary outcome. Based on area under curve values (AUC), ML models, including CatBoost (AUC = 0.76; 95% CI: 0.73–0.80 in MIMIC‐IV; 0.77; 95% CI: 0.72–0.83 in eICU), Gradient Boosting (AUC = 0.75; 95% CI: 0.72–0.79 and 0.74; 95% CI: 0.68–0.80) and XGBoost (AUC = 0.74; 95% CI: 0.70–0.77 and 0.76; 95% CI: 0.71–0.82), outperformed traditional scoring systems. Interpretability analysis via SHAP consistently highlighted TITR as the most influential factor in mortality prediction. Conclusions: These findings underscore the critical role of TITR in outcome prediction and demonstrate both the superiority and interpretability of ML models for risk stratification and decision support. Achieving higher TITR is associated with improved outcomes, highlighting the importance of dynamic glucose control in this population. Relevance to Clinical Practice: The findings offer evidence‐based guidance for ICU nursing interventions, highlighting TITR as a key modifiable factor for improving outcomes for patients with CS. The strong performance of ML models supports their clinical application for more accurate risk stratification, while identification of TITR as the primary mortality predictor—reinforced by transparent SHAP explanations—provides actionable insights to guide early, targeted interventions.
- Open Access
- 23 May 2024
- Published by Elsevier in SLAS Technology
- Vol. 29 (4) , 100149
Machine-learning models for diagnosis of rotator cuff tears in osteoporosis patients based on anteroposterior X-rays of the shoulder joint
- 23 May 2024
- Published by Elsevier in SLAS Technology
- Vol. 29 (4) , 100149
Open AccessMachine-learning models for diagnosis of rotator cuff tears in osteoporosis patients based on anteroposterior X-rays of the shoulder joint